These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7966703

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of (L)-cysteine and (L)-2-oxothiazolidine-4-carboxylic acid (OTZ) on urinary oxalate excretion: studies using a hyperoxaluric rat model.
    Baker PW, Rofe AM, Bais R.
    J Urol; 1998 Jun; 159(6):2177-81. PubMed ID: 9598565
    [Abstract] [Full Text] [Related]

  • 3. The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion.
    Holmes RP, Assimos DG, Leaf CD, Whalen JJ.
    J Urol; 1997 Jul; 158(1):34-7. PubMed ID: 9186317
    [Abstract] [Full Text] [Related]

  • 4. (L)-2-oxothiazolidine-4-carboxylate in the treatment of primary hyperoxaluria type 1.
    Holmes RP, Assimos DG, Wilson DM, Milliner DS.
    BJU Int; 2001 Dec; 88(9):858-62. PubMed ID: 11851603
    [Abstract] [Full Text] [Related]

  • 5. Formation of the L-cysteine-glyoxylate adduct is the mechanism by which L-cysteine decreases oxalate production from glycollate in rat hepatocytes.
    Baker PW, Bais R, Rofe AM.
    Biochem J; 1994 Sep 15; 302 ( Pt 3)(Pt 3):753-7. PubMed ID: 7945199
    [Abstract] [Full Text] [Related]

  • 6. L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human.
    Porta P, Aebi S, Summer K, Lauterburg BH.
    J Pharmacol Exp Ther; 1991 Apr 15; 257(1):331-4. PubMed ID: 2019996
    [Abstract] [Full Text] [Related]

  • 7. Effect of dietary protein deficiency and L-2-oxothiazolidine-4-carboxylate on the diurnal rhythm of hepatic glutathione in the rat.
    Bauman PF, Smith TK, Bray TM.
    J Nutr; 1988 Aug 15; 118(8):1049-54. PubMed ID: 3404284
    [Abstract] [Full Text] [Related]

  • 8. Urinary oxalate excretion in premature infants: effect of human milk versus formula feeding.
    Campfield T, Braden G, Flynn-Valone P, Clark N.
    Pediatrics; 1994 Nov 15; 94(5):674-8. PubMed ID: 7936894
    [Abstract] [Full Text] [Related]

  • 9. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
    Terrill JR, Boyatzis A, Grounds MD, Arthur PG.
    Int J Biochem Cell Biol; 2013 Sep 15; 45(9):2097-108. PubMed ID: 23892094
    [Abstract] [Full Text] [Related]

  • 10. L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet.
    Jain A, Madsen DC, Auld PA, Frayer WW, Schwartz MK, Meister A, Mårtensson J.
    J Nutr; 1995 Apr 15; 125(4):851-6. PubMed ID: 7722686
    [Abstract] [Full Text] [Related]

  • 11. L-2-oxothiazolidine-4-carboxylate as a cysteine precursor: efficacy for growth and hepatic glutathione synthesis in chicks and rats.
    Chung TK, Funk MA, Baker DH.
    J Nutr; 1990 Feb 15; 120(2):158-65. PubMed ID: 2313379
    [Abstract] [Full Text] [Related]

  • 12. The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat.
    Iimuro Y, Bradford BU, Yamashina S, Rusyn I, Nakagami M, Enomoto N, Kono H, Frey W, Forman D, Brenner D, Thurman RG.
    Hepatology; 2000 Feb 15; 31(2):391-8. PubMed ID: 10655262
    [Abstract] [Full Text] [Related]

  • 13. Effects of L-2-oxothiazolidine-4-carboxylate, a cysteine pro-drug, on teratogenicity of 5-fluorouracil in mice.
    Naya M, Noguchi M, Mataki Y, Deguchi T, Yasuda M.
    Hiroshima J Med Sci; 1990 Sep 15; 39(3):79-82. PubMed ID: 2283306
    [Abstract] [Full Text] [Related]

  • 14. The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine.
    Banks MF, Stipanuk MH.
    J Nutr; 1994 Mar 15; 124(3):378-87. PubMed ID: 8120657
    [Abstract] [Full Text] [Related]

  • 15. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 16. Selective elevation of glutathione levels in target tissues with L-2-oxothiazolidine-4-carboxylate (OTC) protects against hyperoxia-induced lung damage in protein-energy malnourished rats: implications for a new treatment strategy.
    Levy MA, Sikorski B, Bray TM.
    J Nutr; 1998 Apr 07; 128(4):671-6. PubMed ID: 9521626
    [Abstract] [Full Text] [Related]

  • 17. Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice.
    Dizdar N, Kullman A, Kågedal B.
    Cancer Chemother Pharmacol; 2000 Apr 07; 45(3):192-8. PubMed ID: 10663636
    [Abstract] [Full Text] [Related]

  • 18. Tissue contents and urinary excretion of taurine after administration of L-cysteine and L-2-oxothiazolidine-4-carboxylate to rats.
    Taguchi T, Akagi R, Ubuka T.
    Acta Med Okayama; 1990 Jun 07; 44(3):123-8. PubMed ID: 2382577
    [Abstract] [Full Text] [Related]

  • 19. Elevation of lung glutathione by oral supplementation of L-2-oxothiazolidine-4-carboxylate protects against oxygen toxicity in protein-energy malnourished rats.
    Taylor CG, Bauman PF, Sikorski B, Bray TM.
    FASEB J; 1992 Sep 07; 6(12):3101-7. PubMed ID: 1521740
    [Abstract] [Full Text] [Related]

  • 20. Effect of L-2-oxothiazolidine-4-carboxylate administration on glutathione and cysteine concentrations in guinea pig liver and kidney.
    Nishina H, Ohta J, Ubuka T.
    Physiol Chem Phys Med NMR; 1987 Sep 07; 19(1):9-13. PubMed ID: 3615644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.